Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of Protein C, but Not Protein S or Antithrombin With Ischemic Stroke: Bidirectional Two-Sample Mendelian Randomization and Meta-Analysis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Same author

Adenosine metabolism as an endogenous protective mechanism in response to upstream ischemic injury.

Frontiers in molecular biosciences·2026

Same author

Helical nanoplatelet superlattices assembled from green emissive CsPbI<sub>3</sub> nanoplatelets.

Chemical communications (Cambridge, England)·2026

Same author

Antibody glyco-optimization and site-specific conjugation enhance the immune-stimulating activity of antibody-TLR ligand conjugates.

The Journal of biological chemistry·2026

Same author

Targeting EHMT2 inhibition in glioblastoma: effects on tumor progression and STAT3 signaling.

Translational cancer research·2026

Same author

High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

Blood·2026

Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026

Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026

Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026

Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026

Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026

Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 4, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

HIV-1 immunopathogenesis in humanized mouse models.

Liguo Zhang¹, Lishan Su

¹Key Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. liguozhang@ibp.ac.cn

Cellular & Molecular Immunology

|April 17, 2012

Summary

This summary is machine-generated.

Humanized mice, developed using human stem cells, effectively model human immune responses and HIV-1 infection. These advanced mouse models are crucial for understanding HIV-1 pathogenesis and developing new immunotherapies.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Humanized NOD/SCID/IL2rγ^null (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jan 4, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Humanized NOD/SCID/IL2rγ^null (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Area of Science:

Immunology
Infectious Diseases
Animal Models

Background:

Advances in chimeric mouse technology have significantly improved the construction of humanized immune systems.
Immunodeficient mice transplanted with human hematopoietic stem cells exhibit development of multiple human immune cell lineages.

Purpose of the Study:

To evaluate the utility of humanized mice as a model for studying human immunodeficiency virus type I (HIV-1) infection and immunopathogenesis.
To explore the potential of humanized mice for developing novel immune-based therapies against HIV-1.

Main Methods:

Transplantation of human hematopoietic stem cells into immunodeficient mice to create humanized immune systems.
Challenging humanized mice with HIV-1 to assess infection dynamics and immune responses.

Main Results:

Humanized mice demonstrated the development of functional humoral and cellular immune responses.
HIV-1 infection in humanized mice led to CD4(+) T-cell depletion and non-specific immune activation, mirroring human HIV-1 immunopathology.

Conclusions:

Humanized mice provide an optimal preclinical model for investigating HIV-1 immunopathogenesis mechanisms.
This model holds significant promise for the development and testing of innovative immune-based therapeutic strategies for HIV-1.